ArticleTranslational andrology and urology2025
Vibegron for overactive bladder in men with benign prostatic hyperplasia/obstruction: insights from the COURAGE trial.
Hossein Saadat et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.